Vaccine-Induced or Hybrid Immunity and COVID-19-Associated Mortality During the Omicron Wave.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 37013438.
- Also identified by DOI 10.3238/arztebl.m2023.0051 and PMC identifier 10277809.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
It is not yet entirely clear to what extent vaccine-induced or hybrid immunity offers protection from death during the omicron wave of the COVID-19 pandemic in Germany. In this retrospective study, we evaluated 470 159 cases aged ≥ 60 years in the German federal state of Bavaria who tested positive for SARS-CoV-2 between 1 January and 30 June 2022. Cox models were used to estimate adjusted hazard ratios (aHR) for dying within 60 days of the infection, depending on sex, age, time of infection, and different levels of immunity. Over the period of observation, 3836 COVID-19-associated deaths were registered (case fatality rate 0.82%). The risk of death was significantly lower in cases with a higher level of immunity than in unvaccinated cases (aHR for a full primary level of immunity if reached less than 6 months before the date of the infection: 0.30, 95% confidence interval [0.23; 0.39]; if reached more than 6 months before: aHR 0.46 [0.35; 0.60]). A boosted level of immunity lowered the risk of death even further (if reached less than 3 months before the infection: aHR 0.17 [0.15; 0.20]; if reached more than 3 months before: aHR 0.25 [0.21; 0.29]). Among elderly persons in Bavaria, a higher immunity level was associated with a substantial degree of protection against death during the Omicron wave; however, the strength of protection may have diminished somewhat over time.
Medical subject headings
- COVID-19